Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
Product Description
Docetaxel 99% is a high-purity pharmaceutical active ingredient (API) widely used in oncology drug development and commercial chemotherapy formulations. As a member of the taxane class, Docetaxel plays a critical role in modern cancer treatment pipelines and is commonly utilized in injectable dosage forms under strict regulatory standards.
Global demand for Plant Extracts, Nutritional Ingredients, and advanced pharmaceutical APIs continues to rise, with Docetaxel positioned as a key compound in oncology-focused Supplement Contract Manufacturing and pharmaceutical production chains.
Content Note: Prepared by our technical team based on current scientific literature. Health claims comply with FDA/EFSA guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (2004), docetaxel-based regimens demonstrated improved response rates in patients with advanced breast cancer compared to standard chemotherapy protocols.
According to a study in The Lancet Oncology (2008), docetaxel showed significant clinical benefit in combination therapy for non-small cell lung cancer, supporting its role in first-line treatment strategies.
Docetaxel 99% is manufactured under controlled GMP conditions to ensure pharmaceutical-grade consistency, purity, and stability.
| Specification | Standard |
|---|---|
| Active Ingredient | Docetaxel |
| Purity | ≥ 99% |
| Appearance | White to off-white powder |
| Test Method | HPLC |
| Form | Sterile API / Lyophilized powder |
| Storage | 2–8°C, protected from light |
This ingredient is widely used in Pharmaceutical Enzymes, Vitamins formulation systems, and advanced Nutritional Fortifiers research pipelines for oncology support compounds.
The quality of Docetaxel 99% depends heavily on synthesis route, purification technology, and sterile processing environment.
| Production Stage | Quality Impact |
|---|---|
| Semi-synthesis from natural precursors | Ensures structural integrity and bioactivity |
| Advanced chromatography purification | Improves impurity profile and safety compliance |
| Sterile freeze-drying process | Enhances stability for injectable formulations |
| API | Mechanism | Primary Use |
|---|---|---|
| Docetaxel | Microtubule stabilization | Breast, lung, prostate cancer |
| Paclitaxel | Microtubule inhibition | Broad-spectrum chemotherapy |
| Doxorubicin | DNA intercalation | Hematologic & solid tumors |
Docetaxel 99% is primarily used in pharmaceutical oncology formulations and advanced drug development pipelines.
It is widely integrated into Sports Nutrition Ingredients research systems, Antioxidants studies, and advanced Anti-aging Ingredients pharmaceutical modeling (non-therapeutic research context).
We provide high-standard pharmaceutical-grade Docetaxel 99% with strict compliance to international manufacturing systems.
It is primarily used as an active pharmaceutical ingredient in chemotherapy drug production for cancer treatment applications.
Yes, it is commonly processed into sterile injectable dosage forms under GMP-compliant manufacturing systems.
The standard purity is ≥99%, verified through HPLC analytical methods.
It should be stored at 2–8°C in a dry, light-protected environment to maintain stability.
Yes, OEM and private label services are available for pharmaceutical clients and contract manufacturers.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.